Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01177202 · ClinicalTrials.gov registry record · Phase 1
Study of the Safety and Immunogenicity of H1N1 Vaccine
A Phase 1 study, sponsored by Fraunhofer, Center for Molecular Biotechnology.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT01177202: Completed Phase 1 study, sponsored by Fraunhofer, Center for Molecular Biotechnology.
NCT01177202 is a Phase 1 study that has completed, run by Fraunhofer, Center for Molecular Biotechnology. The registered enrollment target is 80 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01177202, a Phase 1 study, has completed, sponsored by Fraunhofer, Center for Molecular Biotechnology.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The Purpose Of This Study Is To Assess The Safety, Immunogenicity, And Tolerability Of A H1N1 Vaccine In Healthy Adults
Primary Outcome
The primary objective of this study is to assess the safety, reactogenicity, and tolerability of the HAC1 vaccine formulations delivered intramuscularly at doses of 15 μg, 45 μg or 90 µg (unadjuvanted or adjuvanted) in healthy adults 18 - 50 years of age.
Interventions
- BIOLOGICAL HAC1 Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-10 |
| Phase | Phase 1 |
What the finished NCT01177202 record still lists
NCT01177202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 1 intervention - of which HAC1 Vaccine is the first listed.
NCT01177202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01177202 about?
NCT01177202 is a clinical study titled "Study of the Safety and Immunogenicity of H1N1 Vaccine". The Purpose Of This Study Is To Assess The Safety, Immunogenicity, And Tolerability Of A H1N1 Vaccine In Healthy Adults
What is the current status of trial NCT01177202?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2010-09. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01177202?
The interventions under investigation include: HAC1 Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01177202?
This trial is sponsored by Fraunhofer, Center for Molecular Biotechnology, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01177202's enrollment target sits among peer trials
80 672nd of 2000 higher than 1,305 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia